Mondrian Investment Partners LTD Has $107.23 Million Position in Kenvue Inc. (NYSE:KVUE)

Key Points

• Mondrian Investment Partners LTD reduced its stake in Kenvue Inc. by 15.9% in the first quarter, now holding approximately 4.47 million shares worth $107.23 million.
• Several hedge funds, including Prudential PLC and Clal Insurance Enterprises Holdings Ltd, increased their holdings in Kenvue during the same period, indicating mixed investor sentiment.
• Kenvue declared a quarterly dividend of $0.2075 per share, which represents a 3.8% yield and an increase from the previous dividend of $0.21.

Mondrian Investment Partners LTD trimmed its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 15.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,471,693 shares of the company's stock after selling 847,394 shares during the quarter. Kenvue comprises approximately 1.8% of Mondrian Investment Partners LTD's holdings, making the stock its 29th largest position. Mondrian Investment Partners LTD owned 0.23% of Kenvue worth $107,231,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of KVUE. Rockefeller Capital Management L.P. lifted its stake in shares of Kenvue by 5.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 185,372 shares of the company's stock worth $3,958,000 after buying an additional 9,514 shares during the last quarter. Sagespring Wealth Partners LLC acquired a new stake in shares of Kenvue in the fourth quarter worth $303,000. Keystone Financial Group lifted its stake in shares of Kenvue by 4.8% in the fourth quarter. Keystone Financial Group now owns 12,736 shares of the company's stock worth $272,000 after buying an additional 578 shares during the last quarter. SageView Advisory Group LLC bought a new position in Kenvue during the fourth quarter worth $333,000. Finally, Mariner LLC increased its position in Kenvue by 50.7% during the fourth quarter. Mariner LLC now owns 259,420 shares of the company's stock worth $5,538,000 after acquiring an additional 87,321 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

KVUE has been the topic of a number of research reports. Canaccord Genuity Group dropped their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Barclays cut their price objective on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, July 15th. JPMorgan Chase & Co. cut their price objective on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a report on Friday, July 25th. UBS Group cut their price objective on Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Finally, Citigroup cut their price objective on Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a report on Tuesday, July 15th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Kenvue has a consensus rating of "Hold" and an average target price of $24.38.

Kenvue Price Performance

Shares of NYSE:KVUE traded down $0.66 during midday trading on Thursday, reaching $21.06. The company's stock had a trading volume of 14,760,615 shares, compared to its average volume of 18,421,518. The business's fifty day simple moving average is $21.55 and its 200-day simple moving average is $22.42. The company has a market capitalization of $40.41 billion, a P/E ratio of 28.45, a P/E/G ratio of 3.12 and a beta of 0.83. Kenvue Inc. has a fifty-two week low of $19.75 and a fifty-two week high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion for the quarter, compared to analysts' expectations of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%. The firm's quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.32 earnings per share. As a group, equities research analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th will be issued a $0.2075 dividend. This is an increase from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a yield of 3.9%. The ex-dividend date is Wednesday, August 13th. Kenvue's dividend payout ratio (DPR) is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.